Shares of Pfizer Inc. PFE slid 1.20% to $26.42 Wednesday, on what proved to be an all-around mixed trading session for the ...

Pfizer on Monday named the former head of the U.S. health regulator's drug evaluation unit, Patrizia Cavazzoni, as its chief ...

SpringWorks Therapeutics sprung out of Pfizer’s storeroom, when a rare disease advocacy group pushed to keep a program for ...

The hiring of a former top FDA official amplifies "revolving door" criticism at the worst possible time, STAT's Adam ...

Pfizer has teamed up with Summit Therapeutics to assess whether one of the industry’s hottest cancer candidates works well ...

Bryan Supran, non-executive director and representative of Pfizer, stepped down from the Haleon board of directors. Elizabeth Holmes, the disgraced founder of Theranos, will remain in prison after ...

Patrizia Cavazzoni, formerly the top regulator of the drug division of the FDA, will join Pfizer as chief medical officer.

A study by KFF found that one in four Republican parents now say they've skipped or delayed some childhood vaccines as of ...

Bernstein lowered the firm’s price target on Pfizer (PFE) to $30 from $32 and keeps a Market Perform rating on the shares. The firm notes ...

Pfizer partners with Summit Therapeutics to advance cancer treatments using ADCs and ivonescimab. Click here to find out why ...

Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) yesterday and set a price target of $30.00. The ...

Pfizer said on Monday former head of the US Food and Drug Administration's drug center, Patrizia Cavazzoni, will join the ...